Skip to main content

Humanigen, Inc

HGENDelisted Oct 12, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001293310

Humanigen, Inc was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Oct 20, 2023; 38 institutions reported holding it in 13F filings for Q2 2023, worth $839.7K in total; no superinvestor held it.

Holders of 5% or more of HGEN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Humanigen, Inc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Humanigen, Inc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Humanigen, Inc, newest first.

No Schedule 13D or 13G filings on Humanigen, Inc are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Humanigen, Inc shares.

No Form 144 notices for Humanigen, Inc are on file.